{"entity":{"type":"insider","cik":"0001759910","url":"/insider/0001759910","json_url":"/insider/0001759910.json","name":"Hearne Michael S","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":85,"n_filings":20,"first":"2018-12-10","last":"2021-12-01","span_basis":"filed_date"},"name_variants":[{"name":"Hearne Michael S","source":"filing","n_filings":20,"first_seen":"2018-12-10","last_seen":"2021-12-01"}],"transactions":[{"id":4678880,"accession":"0001209191-21-067347","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-21-067347","line_url":"/filing/0001209191-21-067347","is_derivative":false,"issuer_cik":"0000920465","issuer_name":"LA JOLLA PHARMACEUTICAL CO","issuer_ticker":"LJPC","issuer_name_source":null,"issuer_url":"/issuer/0000920465","owner_cik":null,"owner_name":"Hearne Michael S; TANG KEVIN C; TANG CAPITAL MANAGEMENT LLC; TANG CAPITAL PARTNERS LP","owner_display_name":"Hearne Michael S","owner_url":null,"role":"Director, Officer (Chief Financial Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":177545.0,"shares_display":"177,545","price_per_share":3.7366927764792024,"price_display":"3.74","price_state":"stated","total_value":663431.119,"total_display":"663,431.12","total_whole":"663,431","shares_owned_after":9649224.0,"shares_owned_after_display":"9,649,224","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-12-01","filed_date":"2021-12-01","scope":"insider","n_lines":2},{"id":4678869,"accession":"0001209191-21-067347","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-067347","line_url":"/filing/0001209191-21-067347","is_derivative":false,"issuer_cik":"0000920465","issuer_name":"LA JOLLA PHARMACEUTICAL CO","issuer_ticker":"LJPC","issuer_name_source":null,"issuer_url":"/issuer/0000920465","owner_cik":null,"owner_name":"Hearne Michael S; TANG KEVIN C; TANG CAPITAL MANAGEMENT LLC; TANG CAPITAL PARTNERS LP","owner_display_name":"Hearne Michael S","owner_url":null,"role":"Director, Officer (Chief Financial Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":70342.0,"shares_display":"70,342","price_per_share":3.9465970586562795,"price_display":"3.95","price_state":"stated","total_value":277611.5303,"total_display":"277,611.53","total_whole":"277,612","shares_owned_after":9785479.0,"shares_owned_after_display":"9,785,479","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-11-30","filed_date":"2021-12-01","scope":"insider","n_lines":2},{"id":4678859,"accession":"0001209191-21-067347","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-067347","line_url":"/filing/0001209191-21-067347#line-1","is_derivative":false,"issuer_cik":"0000920465","issuer_name":"LA JOLLA PHARMACEUTICAL CO","issuer_ticker":"LJPC","issuer_name_source":null,"issuer_url":"/issuer/0000920465","owner_cik":null,"owner_name":"Hearne Michael S; TANG KEVIN C; TANG CAPITAL MANAGEMENT LLC; TANG CAPITAL PARTNERS LP","owner_display_name":"Hearne Michael S","owner_url":null,"role":"Director, Officer (Chief Financial Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":193403.0,"shares_display":"193,403","price_per_share":4.1008,"price_display":"4.10","price_state":"stated","total_value":793107.0224,"total_display":"793,107.02","total_whole":"793,107","shares_owned_after":9855821.0,"shares_owned_after_display":"9,855,821","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-11-29","filed_date":"2021-12-01","scope":"insider"},{"id":4746659,"accession":"0001209191-21-065826","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-21-065826","line_url":"/filing/0001209191-21-065826#line-8","is_derivative":false,"issuer_cik":"0001178579","issuer_name":"Odonate Therapeutics, Inc.","issuer_ticker":"ODT","issuer_name_source":null,"issuer_url":"/issuer/0001178579","owner_cik":null,"owner_name":"TANG CAPITAL PARTNERS LP; TANG KEVIN C; TANG CAPITAL MANAGEMENT LLC; Hearne Michael S","owner_display_name":"TANG CAPITAL PARTNERS LP","owner_url":null,"role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":365289.0,"shares_display":"365,289","price_per_share":1.9161,"price_display":"1.92","price_state":"stated","total_value":699930.2529,"total_display":"699,930.25","total_whole":"699,930","shares_owned_after":12767435.0,"shares_owned_after_display":"12,767,435","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-11-19","filed_date":"2021-11-19","scope":"insider"},{"id":4746657,"accession":"0001209191-21-065826","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-21-065826","line_url":"/filing/0001209191-21-065826","is_derivative":false,"issuer_cik":"0001178579","issuer_name":"Odonate Therapeutics, Inc.","issuer_ticker":"ODT","issuer_name_source":null,"issuer_url":"/issuer/0001178579","owner_cik":null,"owner_name":"TANG CAPITAL PARTNERS LP; TANG KEVIN C; TANG CAPITAL MANAGEMENT LLC; Hearne Michael S","owner_display_name":"TANG CAPITAL PARTNERS LP","owner_url":null,"role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1094265.0,"shares_display":"1,094,265","price_per_share":1.9025366190091066,"price_display":"1.90","price_state":"stated","total_value":2081879.2334,"total_display":"2,081,879.23","total_whole":"2,081,879","shares_owned_after":13514566.0,"shares_owned_after_display":"13,514,566","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-11-18","filed_date":"2021-11-19","scope":"insider","n_lines":3},{"id":4746642,"accession":"0001209191-21-065826","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-065826","line_url":"/filing/0001209191-21-065826","is_derivative":false,"issuer_cik":"0001178579","issuer_name":"Odonate Therapeutics, Inc.","issuer_ticker":"ODT","issuer_name_source":null,"issuer_url":"/issuer/0001178579","owner_cik":null,"owner_name":"TANG CAPITAL PARTNERS LP; TANG KEVIN C; TANG CAPITAL MANAGEMENT LLC; Hearne Michael S","owner_display_name":"TANG CAPITAL PARTNERS LP","owner_url":null,"role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1287577.0,"shares_display":"1,287,577","price_per_share":2.29015238723587,"price_display":"2.29","price_state":"stated","total_value":2948747.5403,"total_display":"2,948,747.54","total_whole":"2,948,748","shares_owned_after":14514566.0,"shares_owned_after_display":"14,514,566","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-11-17","filed_date":"2021-11-19","scope":"insider","n_lines":4},{"id":4093588,"accession":"0001209191-21-036939","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-036939","line_url":"/filing/0001209191-21-036939","is_derivative":false,"issuer_cik":"0000920465","issuer_name":"LA JOLLA PHARMACEUTICAL CO","issuer_ticker":"LJPC","issuer_name_source":null,"issuer_url":"/issuer/0000920465","owner_cik":null,"owner_name":"TANG KEVIN C; TANG CAPITAL MANAGEMENT LLC; TANG CAPITAL PARTNERS LP; Hearne Michael S","owner_display_name":"TANG KEVIN C","owner_url":null,"role":"Director, Officer (Chief Financial Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":59092.0,"shares_display":"59,092","price_per_share":4.4664416130779125,"price_display":"4.47","price_state":"stated","total_value":263930.9678,"total_display":"263,930.97","total_whole":"263,931","shares_owned_after":10049224.0,"shares_owned_after_display":"10,049,224","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-06-01","filed_date":"2021-06-01","scope":"insider","n_lines":2},{"id":4093582,"accession":"0001209191-21-036939","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-036939","line_url":"/filing/0001209191-21-036939","is_derivative":false,"issuer_cik":"0000920465","issuer_name":"LA JOLLA PHARMACEUTICAL CO","issuer_ticker":"LJPC","issuer_name_source":null,"issuer_url":"/issuer/0000920465","owner_cik":null,"owner_name":"TANG KEVIN C; TANG CAPITAL MANAGEMENT LLC; TANG CAPITAL PARTNERS LP; Hearne Michael S","owner_display_name":"TANG KEVIN C","owner_url":null,"role":"Director, Officer (Chief Financial Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":185928.0,"shares_display":"185,928","price_per_share":4.473572916397745,"price_display":"4.47","price_state":"stated","total_value":831762.4652,"total_display":"831,762.47","total_whole":"831,762","shares_owned_after":9990132.0,"shares_owned_after_display":"9,990,132","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-05-27","filed_date":"2021-06-01","scope":"insider","n_lines":2},{"id":5160925,"accession":"0001209191-21-035962","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-035962","line_url":"/filing/0001209191-21-035962#line-4","is_derivative":false,"issuer_cik":"0000920465","issuer_name":"LA JOLLA PHARMACEUTICAL CO","issuer_ticker":"LJPC","issuer_name_source":null,"issuer_url":"/issuer/0000920465","owner_cik":null,"owner_name":"TANG CAPITAL PARTNERS LP; TANG KEVIN C; TANG CAPITAL MANAGEMENT LLC; Hearne Michael S","owner_display_name":"TANG CAPITAL PARTNERS LP","owner_url":null,"role":"Director, Officer (Chief Financial Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":166932.0,"shares_display":"166,932","price_per_share":4.2578,"price_display":"4.26","price_state":"stated","total_value":710763.0696,"total_display":"710,763.07","total_whole":"710,763","shares_owned_after":9804204.0,"shares_owned_after_display":"9,804,204","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-05-26","filed_date":"2021-05-26","scope":"insider"},{"id":5160906,"accession":"0001209191-21-035962","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-035962","line_url":"/filing/0001209191-21-035962","is_derivative":false,"issuer_cik":"0000920465","issuer_name":"LA JOLLA PHARMACEUTICAL CO","issuer_ticker":"LJPC","issuer_name_source":null,"issuer_url":"/issuer/0000920465","owner_cik":null,"owner_name":"TANG CAPITAL PARTNERS LP; TANG KEVIN C; TANG CAPITAL MANAGEMENT LLC; Hearne Michael S","owner_display_name":"TANG CAPITAL PARTNERS LP","owner_url":null,"role":"Director, Officer (Chief Financial Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":127379.0,"shares_display":"127,379","price_per_share":3.789745491800061,"price_display":"3.79","price_state":"stated","total_value":482733.991,"total_display":"482,733.99","total_whole":"482,734","shares_owned_after":9605490.0,"shares_owned_after_display":"9,605,490","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-05-25","filed_date":"2021-05-26","scope":"insider","n_lines":2},{"id":5160904,"accession":"0001209191-21-035962","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-035962","line_url":"/filing/0001209191-21-035962#line-1","is_derivative":false,"issuer_cik":"0000920465","issuer_name":"LA JOLLA PHARMACEUTICAL CO","issuer_ticker":"LJPC","issuer_name_source":null,"issuer_url":"/issuer/0000920465","owner_cik":null,"owner_name":"TANG CAPITAL PARTNERS LP; TANG KEVIN C; TANG CAPITAL MANAGEMENT LLC; Hearne Michael S","owner_display_name":"TANG CAPITAL PARTNERS LP","owner_url":null,"role":"Director, Officer (Chief Financial Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":104403.0,"shares_display":"104,403","price_per_share":3.6803,"price_display":"3.68","price_state":"stated","total_value":384234.3609,"total_display":"384,234.36","total_whole":"384,234","shares_owned_after":9509893.0,"shares_owned_after_display":"9,509,893","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-05-24","filed_date":"2021-05-26","scope":"insider"},{"id":2692082,"accession":"0001209191-20-065024","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-20-065024","line_url":"/filing/0001209191-20-065024","is_derivative":false,"issuer_cik":"0001178579","issuer_name":"Odonate Therapeutics, Inc.","issuer_ticker":"ODT","issuer_name_source":null,"issuer_url":"/issuer/0001178579","owner_cik":null,"owner_name":"TANG CAPITAL PARTNERS LP; TANG KEVIN C; TANG CAPITAL MANAGEMENT LLC; Hearne Michael S","owner_display_name":"TANG CAPITAL PARTNERS LP","owner_url":null,"role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":139138.0,"shares_display":"139,138","price_per_share":15.580598073854734,"price_display":"15.58","price_state":"stated","total_value":2167853.2548,"total_display":"2,167,853.25","total_whole":"2,167,853","shares_owned_after":15514566.0,"shares_owned_after_display":"15,514,566","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-12-23","filed_date":"2020-12-23","scope":"insider","n_lines":2},{"id":2692075,"accession":"0001209191-20-065024","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-20-065024","line_url":"/filing/0001209191-20-065024","is_derivative":false,"issuer_cik":"0001178579","issuer_name":"Odonate Therapeutics, Inc.","issuer_ticker":"ODT","issuer_name_source":null,"issuer_url":"/issuer/0001178579","owner_cik":null,"owner_name":"TANG CAPITAL PARTNERS LP; TANG KEVIN C; TANG CAPITAL MANAGEMENT LLC; Hearne Michael S","owner_display_name":"TANG CAPITAL PARTNERS LP","owner_url":null,"role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":74502.0,"shares_display":"74,502","price_per_share":14.866543424337602,"price_display":"14.87","price_state":"stated","total_value":1107587.2182,"total_display":"1,107,587.22","total_whole":"1,107,587","shares_owned_after":15338782.0,"shares_owned_after_display":"15,338,782","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-12-22","filed_date":"2020-12-23","scope":"insider","n_lines":2},{"id":2692066,"accession":"0001209191-20-065024","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-065024","line_url":"/filing/0001209191-20-065024#line-1","is_derivative":false,"issuer_cik":"0001178579","issuer_name":"Odonate Therapeutics, Inc.","issuer_ticker":"ODT","issuer_name_source":null,"issuer_url":"/issuer/0001178579","owner_cik":null,"owner_name":"TANG CAPITAL PARTNERS LP; TANG KEVIN C; TANG CAPITAL MANAGEMENT LLC; Hearne Michael S","owner_display_name":"TANG CAPITAL PARTNERS LP","owner_url":null,"role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":62144.0,"shares_display":"62,144","price_per_share":14.5753,"price_display":"14.58","price_state":"stated","total_value":905767.4432,"total_display":"905,767.44","total_whole":"905,767","shares_owned_after":15300926.0,"shares_owned_after_display":"15,300,926","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-12-21","filed_date":"2020-12-23","scope":"insider"},{"id":2192084,"accession":"0001209191-20-052437","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-052437","line_url":"/filing/0001209191-20-052437#line-2","is_derivative":false,"issuer_cik":"0001178579","issuer_name":"Odonate Therapeutics, Inc.","issuer_ticker":"ODT","issuer_name_source":null,"issuer_url":"/issuer/0001178579","owner_cik":null,"owner_name":"Hearne Michael S; TANG CAPITAL PARTNERS LP; Lemkey John G; TANG KEVIN C; TANG CAPITAL MANAGEMENT LLC","owner_display_name":"Hearne Michael S","owner_url":null,"role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10882.0,"shares_display":"10,882","price_per_share":13.8484,"price_display":"13.85","price_state":"stated","total_value":150698.2888,"total_display":"150,698.29","total_whole":"150,698","shares_owned_after":15238782.0,"shares_owned_after_display":"15,238,782","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-09-29","filed_date":"2020-09-30","scope":"insider"},{"id":2192081,"accession":"0001209191-20-052437","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-052437","line_url":"/filing/0001209191-20-052437#line-1","is_derivative":false,"issuer_cik":"0001178579","issuer_name":"Odonate Therapeutics, Inc.","issuer_ticker":"ODT","issuer_name_source":null,"issuer_url":"/issuer/0001178579","owner_cik":null,"owner_name":"Hearne Michael S; TANG CAPITAL PARTNERS LP; Lemkey John G; TANG KEVIN C; TANG CAPITAL MANAGEMENT LLC","owner_display_name":"Hearne Michael S","owner_url":null,"role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":13.0571,"price_display":"13.06","price_state":"stated","total_value":1305710.0,"total_display":"1,305,710.00","total_whole":"1,305,710","shares_owned_after":15227900.0,"shares_owned_after_display":"15,227,900","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-09-28","filed_date":"2020-09-30","scope":"insider"},{"id":2443876,"accession":"0001209191-20-049871","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-20-049871","line_url":"/filing/0001209191-20-049871","is_derivative":false,"issuer_cik":"0000920465","issuer_name":"LA JOLLA PHARMACEUTICAL CO","issuer_ticker":"LJPC","issuer_name_source":null,"issuer_url":"/issuer/0000920465","owner_cik":null,"owner_name":"Hearne Michael S; TANG CAPITAL PARTNERS LP; TANG KEVIN C; TANG CAPITAL MANAGEMENT LLC","owner_display_name":"Hearne Michael S","owner_url":null,"role":"Director, Officer (Chief Financial Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":126665.0,"shares_display":"126,665","price_per_share":4.025898664982434,"price_display":"4.03","price_state":"stated","total_value":509940.4544,"total_display":"509,940.45","total_whole":"509,940","shares_owned_after":9405490.0,"shares_owned_after_display":"9,405,490","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-09-09","filed_date":"2020-09-09","scope":"insider","n_lines":2},{"id":2443869,"accession":"0001209191-20-049871","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-049871","line_url":"/filing/0001209191-20-049871#line-2","is_derivative":false,"issuer_cik":"0000920465","issuer_name":"LA JOLLA PHARMACEUTICAL CO","issuer_ticker":"LJPC","issuer_name_source":null,"issuer_url":"/issuer/0000920465","owner_cik":null,"owner_name":"Hearne Michael S; TANG CAPITAL PARTNERS LP; TANG KEVIN C; TANG CAPITAL MANAGEMENT LLC","owner_display_name":"Hearne Michael S","owner_url":null,"role":"Director, Officer (Chief Financial Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":84152.0,"shares_display":"84,152","price_per_share":3.904,"price_display":"3.90","price_state":"stated","total_value":328529.408,"total_display":"328,529.41","total_whole":"328,529","shares_owned_after":9278825.0,"shares_owned_after_display":"9,278,825","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-09-08","filed_date":"2020-09-09","scope":"insider"},{"id":2443866,"accession":"0001209191-20-049871","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-049871","line_url":"/filing/0001209191-20-049871#line-1","is_derivative":false,"issuer_cik":"0000920465","issuer_name":"LA JOLLA PHARMACEUTICAL CO","issuer_ticker":"LJPC","issuer_name_source":null,"issuer_url":"/issuer/0000920465","owner_cik":null,"owner_name":"Hearne Michael S; TANG CAPITAL PARTNERS LP; TANG KEVIN C; TANG CAPITAL MANAGEMENT LLC","owner_display_name":"Hearne Michael S","owner_url":null,"role":"Director, Officer (Chief Financial Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":67552.0,"shares_display":"67,552","price_per_share":3.8246,"price_display":"3.82","price_state":"stated","total_value":258359.3792,"total_display":"258,359.38","total_whole":"258,359","shares_owned_after":9194673.0,"shares_owned_after_display":"9,194,673","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-09-04","filed_date":"2020-09-09","scope":"insider"},{"id":3323559,"accession":"0001209191-20-048868","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-048868","line_url":"/filing/0001209191-20-048868#line-1","is_derivative":false,"issuer_cik":"0001178579","issuer_name":"Odonate Therapeutics, Inc.","issuer_ticker":"ODT","issuer_name_source":null,"issuer_url":"/issuer/0001178579","owner_cik":null,"owner_name":"Hearne Michael S; TANG KEVIN C; TANG CAPITAL MANAGEMENT LLC; TANG CAPITAL PARTNERS LP; Lemkey John G","owner_display_name":"Hearne Michael S","owner_url":null,"role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1052631.0,"shares_display":"1,052,631","price_per_share":14.25,"price_display":"14.25","price_state":"stated","total_value":14999991.75,"total_display":"14,999,991.75","total_whole":"14,999,992","shares_owned_after":15127900.0,"shares_owned_after_display":"15,127,900","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-08-28","filed_date":"2020-09-01","scope":"insider"},{"id":2471849,"accession":"0001209191-20-046812","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-20-046812","line_url":"/filing/0001209191-20-046812#line-3","is_derivative":false,"issuer_cik":"0000920465","issuer_name":"LA JOLLA PHARMACEUTICAL CO","issuer_ticker":"LJPC","issuer_name_source":null,"issuer_url":"/issuer/0000920465","owner_cik":null,"owner_name":"TANG CAPITAL PARTNERS LP; TANG KEVIN C; TANG CAPITAL MANAGEMENT LLC; Hearne Michael S","owner_display_name":"TANG CAPITAL PARTNERS LP","owner_url":null,"role":"Director, Officer (Chief Financial Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":168669.0,"shares_display":"168,669","price_per_share":3.8756,"price_display":"3.88","price_state":"stated","total_value":653693.5764,"total_display":"653,693.58","total_whole":"653,694","shares_owned_after":9127121.0,"shares_owned_after_display":"9,127,121","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-08-14","filed_date":"2020-08-14","scope":"insider"},{"id":2471842,"accession":"0001209191-20-046812","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-046812","line_url":"/filing/0001209191-20-046812#line-2","is_derivative":false,"issuer_cik":"0000920465","issuer_name":"LA JOLLA PHARMACEUTICAL CO","issuer_ticker":"LJPC","issuer_name_source":null,"issuer_url":"/issuer/0000920465","owner_cik":null,"owner_name":"TANG CAPITAL PARTNERS LP; TANG KEVIN C; TANG CAPITAL MANAGEMENT LLC; Hearne Michael S","owner_display_name":"TANG CAPITAL PARTNERS LP","owner_url":null,"role":"Director, Officer (Chief Financial Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":219465.0,"shares_display":"219,465","price_per_share":3.6479,"price_display":"3.65","price_state":"stated","total_value":800586.3735,"total_display":"800,586.37","total_whole":"800,586","shares_owned_after":8958452.0,"shares_owned_after_display":"8,958,452","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-08-13","filed_date":"2020-08-14","scope":"insider"},{"id":2471837,"accession":"0001209191-20-046812","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-046812","line_url":"/filing/0001209191-20-046812#line-1","is_derivative":false,"issuer_cik":"0000920465","issuer_name":"LA JOLLA PHARMACEUTICAL CO","issuer_ticker":"LJPC","issuer_name_source":null,"issuer_url":"/issuer/0000920465","owner_cik":null,"owner_name":"TANG CAPITAL PARTNERS LP; TANG KEVIN C; TANG CAPITAL MANAGEMENT LLC; Hearne Michael S","owner_display_name":"TANG CAPITAL PARTNERS LP","owner_url":null,"role":"Director, Officer (Chief Financial Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":43513.0,"shares_display":"43,513","price_per_share":3.4661,"price_display":"3.47","price_state":"stated","total_value":150820.4093,"total_display":"150,820.41","total_whole":"150,820","shares_owned_after":8738987.0,"shares_owned_after_display":"8,738,987","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-08-12","filed_date":"2020-08-14","scope":"insider"},{"id":3009988,"accession":"0001209191-20-034535","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-20-034535","line_url":"/filing/0001209191-20-034535#line-3","is_derivative":false,"issuer_cik":"0000920465","issuer_name":"LA JOLLA PHARMACEUTICAL CO","issuer_ticker":"LJPC","issuer_name_source":null,"issuer_url":"/issuer/0000920465","owner_cik":null,"owner_name":"TANG CAPITAL PARTNERS LP; Hearne Michael S; TANG KEVIN C; TANG CAPITAL MANAGEMENT LLC","owner_display_name":"TANG CAPITAL PARTNERS LP","owner_url":null,"role":"Director, Officer (Chief Financial Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":215812.0,"shares_display":"215,812","price_per_share":4.9378,"price_display":"4.94","price_state":"stated","total_value":1065636.4936,"total_display":"1,065,636.49","total_whole":"1,065,636","shares_owned_after":8695474.0,"shares_owned_after_display":"8,695,474","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-06-04","filed_date":"2020-06-04","scope":"insider"},{"id":3009985,"accession":"0001209191-20-034535","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-034535","line_url":"/filing/0001209191-20-034535#line-2","is_derivative":false,"issuer_cik":"0000920465","issuer_name":"LA JOLLA PHARMACEUTICAL CO","issuer_ticker":"LJPC","issuer_name_source":null,"issuer_url":"/issuer/0000920465","owner_cik":null,"owner_name":"TANG CAPITAL PARTNERS LP; Hearne Michael S; TANG KEVIN C; TANG CAPITAL MANAGEMENT LLC","owner_display_name":"TANG CAPITAL PARTNERS LP","owner_url":null,"role":"Director, Officer (Chief Financial Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":145764.0,"shares_display":"145,764","price_per_share":4.9037,"price_display":"4.90","price_state":"stated","total_value":714782.9268,"total_display":"714,782.93","total_whole":"714,783","shares_owned_after":8479662.0,"shares_owned_after_display":"8,479,662","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-06-03","filed_date":"2020-06-04","scope":"insider"},{"id":3009980,"accession":"0001209191-20-034535","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-034535","line_url":"/filing/0001209191-20-034535#line-1","is_derivative":false,"issuer_cik":"0000920465","issuer_name":"LA JOLLA PHARMACEUTICAL CO","issuer_ticker":"LJPC","issuer_name_source":null,"issuer_url":"/issuer/0000920465","owner_cik":null,"owner_name":"TANG CAPITAL PARTNERS LP; Hearne Michael S; TANG KEVIN C; TANG CAPITAL MANAGEMENT LLC","owner_display_name":"TANG CAPITAL PARTNERS LP","owner_url":null,"role":"Director, Officer (Chief Financial Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":253553.0,"shares_display":"253,553","price_per_share":4.8789,"price_display":"4.88","price_state":"stated","total_value":1237059.7317,"total_display":"1,237,059.73","total_whole":"1,237,060","shares_owned_after":8333898.0,"shares_owned_after_display":"8,333,898","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-06-02","filed_date":"2020-06-04","scope":"insider"},{"id":7927390,"accession":"0001209191-19-039458","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-039458","line_url":"/filing/0001209191-19-039458#line-1","is_derivative":false,"issuer_cik":"0001178579","issuer_name":"Odonate Therapeutics, Inc.","issuer_ticker":"ODT","issuer_name_source":null,"issuer_url":"/issuer/0001178579","owner_cik":null,"owner_name":"TANG CAPITAL PARTNERS LP; Hearne Michael S; Lemkey John G; TANG KEVIN C; TANG CAPITAL MANAGEMENT LLC","owner_display_name":"TANG CAPITAL PARTNERS LP","owner_url":null,"role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":769231.0,"shares_display":"769,231","price_per_share":26.0,"price_display":"26.00","price_state":"stated","total_value":20000006.0,"total_display":"20,000,006.00","total_whole":"20,000,006","shares_owned_after":14075269.0,"shares_owned_after_display":"14,075,269","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-06-26","filed_date":"2019-06-28","scope":"insider"},{"id":8701976,"accession":"0001209191-19-037895","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-19-037895","line_url":"/filing/0001209191-19-037895#line-4","is_derivative":false,"issuer_cik":"0001178579","issuer_name":"Odonate Therapeutics, Inc.","issuer_ticker":"ODT","issuer_name_source":null,"issuer_url":"/issuer/0001178579","owner_cik":null,"owner_name":"TANG KEVIN C; TANG CAPITAL MANAGEMENT LLC; Lemkey John G; Hearne Michael S; TANG CAPITAL PARTNERS LP","owner_display_name":"TANG KEVIN C","owner_url":null,"role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":21350.0,"shares_display":"21,350","price_per_share":26.8862,"price_display":"26.89","price_state":"stated","total_value":574020.37,"total_display":"574,020.37","total_whole":"574,020","shares_owned_after":13306038.0,"shares_owned_after_display":"13,306,038","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-06-18","filed_date":"2019-06-18","scope":"insider"},{"id":8701973,"accession":"0001209191-19-037895","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-19-037895","line_url":"/filing/0001209191-19-037895","is_derivative":false,"issuer_cik":"0001178579","issuer_name":"Odonate Therapeutics, Inc.","issuer_ticker":"ODT","issuer_name_source":null,"issuer_url":"/issuer/0001178579","owner_cik":null,"owner_name":"TANG KEVIN C; TANG CAPITAL MANAGEMENT LLC; Lemkey John G; Hearne Michael S; TANG CAPITAL PARTNERS LP","owner_display_name":"TANG KEVIN C","owner_url":null,"role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10042.0,"shares_display":"10,042","price_per_share":26.810539633539136,"price_display":"26.81","price_state":"stated","total_value":269231.439,"total_display":"269,231.44","total_whole":"269,231","shares_owned_after":13284688.0,"shares_owned_after_display":"13,284,688","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-06-17","filed_date":"2019-06-18","scope":"insider","n_lines":2},{"id":8701968,"accession":"0001209191-19-037895","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-037895","line_url":"/filing/0001209191-19-037895#line-1","is_derivative":false,"issuer_cik":"0001178579","issuer_name":"Odonate Therapeutics, Inc.","issuer_ticker":"ODT","issuer_name_source":null,"issuer_url":"/issuer/0001178579","owner_cik":null,"owner_name":"TANG KEVIN C; TANG CAPITAL MANAGEMENT LLC; Lemkey John G; Hearne Michael S; TANG CAPITAL PARTNERS LP","owner_display_name":"TANG KEVIN C","owner_url":null,"role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":18608.0,"shares_display":"18,608","price_per_share":24.9513,"price_display":"24.95","price_state":"stated","total_value":464293.7904,"total_display":"464,293.79","total_whole":"464,294","shares_owned_after":13274646.0,"shares_owned_after_display":"13,274,646","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-06-14","filed_date":"2019-06-18","scope":"insider"},{"id":8391884,"accession":"0001209191-19-035995","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-19-035995","line_url":"/filing/0001209191-19-035995#line-4","is_derivative":false,"issuer_cik":"0001178579","issuer_name":"Odonate Therapeutics, Inc.","issuer_ticker":"ODT","issuer_name_source":null,"issuer_url":"/issuer/0001178579","owner_cik":null,"owner_name":"Lemkey John G; TANG KEVIN C; TANG CAPITAL MANAGEMENT LLC; TANG CAPITAL PARTNERS LP; Hearne Michael S","owner_display_name":"Lemkey John G","owner_url":null,"role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":26.311,"price_display":"26.31","price_state":"stated","total_value":526220.0,"total_display":"526,220.00","total_whole":"526,220","shares_owned_after":13256038.0,"shares_owned_after_display":"13,256,038","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-06-07","filed_date":"2019-06-10","scope":"insider"},{"id":8391880,"accession":"0001209191-19-035995","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-19-035995","line_url":"/filing/0001209191-19-035995","is_derivative":false,"issuer_cik":"0001178579","issuer_name":"Odonate Therapeutics, Inc.","issuer_ticker":"ODT","issuer_name_source":null,"issuer_url":"/issuer/0001178579","owner_cik":null,"owner_name":"Lemkey John G; TANG KEVIN C; TANG CAPITAL MANAGEMENT LLC; TANG CAPITAL PARTNERS LP; Hearne Michael S","owner_display_name":"Lemkey John G","owner_url":null,"role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":56308.0,"shares_display":"56,308","price_per_share":27.726731995453576,"price_display":"27.73","price_state":"stated","total_value":1561236.8252,"total_display":"1,561,236.83","total_whole":"1,561,237","shares_owned_after":13227350.0,"shares_owned_after_display":"13,227,350","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-06-06","filed_date":"2019-06-10","scope":"insider","n_lines":3},{"id":8158690,"accession":"0001209191-19-034851","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-19-034851","line_url":"/filing/0001209191-19-034851","is_derivative":false,"issuer_cik":"0001178579","issuer_name":"Odonate Therapeutics, Inc.","issuer_ticker":"ODT","issuer_name_source":null,"issuer_url":"/issuer/0001178579","owner_cik":null,"owner_name":"Lemkey John G; TANG KEVIN C; TANG CAPITAL MANAGEMENT LLC; Hearne Michael S; TANG CAPITAL PARTNERS LP","owner_display_name":"Lemkey John G","owner_url":null,"role":"Director, Officer (Chief Executive Officer), Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":39456.0,"shares_display":"39,456","price_per_share":25.865286678832117,"price_display":"25.87","price_state":"stated","total_value":1020540.7512,"total_display":"1,020,540.75","total_whole":"1,020,541","shares_owned_after":13179730.0,"shares_owned_after_display":"13,179,730","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-06-05","filed_date":"2019-06-05","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":"2019-06-05|8158684","ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000920465","name":"LA JOLLA PHARMACEUTICAL CO","url":"/issuer/0000920465","role":"Officer (Chief Financial Officer)","n_filings":6,"first_seen":"2020-06-04","last_seen":"2021-12-01"},{"type":"issuer","type_label":"ISSUER","cik":"0001717452","name":"Odonate Therapeutics, Inc.","url":"/issuer/0001717452","role":"Officer (Chief Financial Officer)","n_filings":14,"first_seen":"2018-12-10","last_seen":"2021-11-19"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001759910","retrieved_at":"2026-08-25T23:53:38+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}